Matthew Corey
Director of Finance/CFO chez PIONEER MERGER CORP.
Profil
Matthew Corey is currently a Director at EdenRoc Sciences LLC, Life Biosciences, Inc., Immetas Therapeutics, Inc., and Iduna Therapeutics, Inc. He is also the Chief Financial Officer at Alpha Wave Global (Venture Capital), Pioneer Merger Corp., and Frontier Acquisition Corp.
Previously, he worked as a Director at Alterity Therapeutics Ltd.
and as CFO, Senior Accountant & Controller at Gruss Capital Management LP.
He also worked as an Auditor at Rothstein Kass LLP from 2006 to 2009.
Corey received his undergraduate degree from Lehigh University and his graduate degree from Seton Hall University School of Law.
Postes actifs de Matthew Corey
| Sociétés | Poste | Début |
|---|---|---|
| PIONEER MERGER CORP. | Director of Finance/CFO | - |
| FRONTIER ACQUISITION CORP. | Director of Finance/CFO | - |
Alpha Wave Global (Venture Capital)
 Alpha Wave Global (Venture Capital) Investment ManagersFinance Alpha Wave Global (Venture Capital) is a venture capital arm of Falcon Edge Capital LP founded in 2012 by Rick Gerson, Navroz Darius Udwadia and Ryan Francis Khoury. The firm is headquartered in New York. | Director of Finance/CFO | 01/04/2019 |
Life Biosciences, Inc.
 Life Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA. | Director/Board Member | - |
| Iduna Therapeutics, Inc. | Director/Board Member | - |
EdenRoc Sciences LLC
 EdenRoc Sciences LLC BiotechnologyHealth Technology EdenRoc Sciences LLC engages in the business of biotechnology. The company was founded in 2016 and is headquartered in Birmingham, MI. | Director/Board Member | - |
Immetas Therapeutics, Inc.
 Immetas Therapeutics, Inc. BiotechnologyHealth Technology Immetas Therapeutics, Inc. develops novel therapeutics that modulates the innate immune system to treat age-related cancers and inflammatory diseases. The company was founded by J. Gene Wang and David A. Sinclair in October 2018 and is headquartered in East Hanover, NJ. | Director/Board Member | - |
Anciens postes connus de Matthew Corey
| Sociétés | Poste | Fin |
|---|---|---|
| Rothstein Kass LLP | Corporate Officer/Principal | 01/01/2009 |
| ALTERITY THERAPEUTICS LIMITED | Director/Board Member | - |
| ░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - |
Formation de Matthew Corey
| Lehigh University | Undergraduate Degree |
| Seton Hall University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ALTERITY THERAPEUTICS LIMITED | Health Technology |
| Entreprise privées | 9 |
|---|---|
Gruss Capital Management LP
 Gruss Capital Management LP Investment ManagersFinance Gruss Capital Management LP is a hedge fund manager headquartered in New York City. The firm was founded in 2000, but traces its roots to the 1940s when the late Joseph Gruss founded Gruss & Co. They are a subsidiary of Gruss Capital Holdings LP. Gruss Capital Management serves as investment manager with discretionary trading authority for various private investment funds. Investors in the funds include, among others: high net-worth individuals, corporations, trusts, charitable institutions, foundations, endowments, financial institutions, corporate pension plans, other US and international institutional investors, and government entities. | Finance |
EdenRoc Sciences LLC
EdenRoc Sciences LLC BiotechnologyHealth Technology EdenRoc Sciences LLC engages in the business of biotechnology. The company was founded in 2016 and is headquartered in Birmingham, MI. | Health Technology |
Alpha Wave Global (Venture Capital)
Alpha Wave Global (Venture Capital) Investment ManagersFinance Alpha Wave Global (Venture Capital) is a venture capital arm of Falcon Edge Capital LP founded in 2012 by Rick Gerson, Navroz Darius Udwadia and Ryan Francis Khoury. The firm is headquartered in New York. | Finance |
| Rothstein Kass LLP | |
Life Biosciences, Inc.
Life Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA. | Electronic Technology |
Immetas Therapeutics, Inc.
Immetas Therapeutics, Inc. BiotechnologyHealth Technology Immetas Therapeutics, Inc. develops novel therapeutics that modulates the innate immune system to treat age-related cancers and inflammatory diseases. The company was founded by J. Gene Wang and David A. Sinclair in October 2018 and is headquartered in East Hanover, NJ. | Health Technology |
Pioneer Merger Corp.
 Pioneer Merger Corp. Financial ConglomeratesFinance Pioneer Merger Corp. is a blank check company, which was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Its objective is to identify, acquire, and operate a business to generate attractive risk-adjusted returns for shareholders by effecting a business combination with a target company that is rapidly growing and ready for public market ownership. The company was founded on October 21, 2020 and is headquartered in New York, NY. | Finance |
Frontier Acquisition Corp.
 Frontier Acquisition Corp. Financial ConglomeratesFinance Frontier Acquisition Corp. is a blank check company, which engages in seeking a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on January 15, 2021 and is headquartered in New York, NY. | Finance |
| Iduna Therapeutics, Inc. |
